CELU
CELU
NASDAQ · Biotechnology

Celularity Inc-A

$0.88
-0.03 (-3.04%)
As of May 16, 2:22 AM ET ·
Financial Highlights (FY 2026)
Revenue
65.86M
Net Income
-70,321,353
Gross Margin
72.4%
Profit Margin
-106.8%
Rev Growth
+36.5%
D/E Ratio
4.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 72.4% 72.4% 53.6% 53.6%
Operating Margin -77.9% -70.2% 20.6% 21.3%
Profit Margin -106.8% -101.4% 22.1% 19.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 65.86M 48.26M 10.25M 10.35M
Gross Profit 47.66M 34.92M 5.50M 5.55M
Operating Income -51,339,521 -33,857,674 2.11M 2.20M
Net Income -70,321,353 -46,375,919 2.27M 1.98M
Gross Margin 72.4% 72.4% 53.6% 53.6%
Operating Margin -77.9% -70.2% 20.6% 21.3%
Profit Margin -106.8% -101.4% 22.1% 19.1%
Rev Growth +36.5% +36.5% +24.9% +1.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 9.66M 9.66M 12.27M 11.63M
Total Equity 2.03M 2.03M 14.31M 15.01M
D/E Ratio 4.75 4.75 0.86 0.77
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -60,985,413 -42,453,390 3.06M 3.48M
Free Cash Flow 1.07M 1.08M